Breast cancer tumor growth estimated through mammography screening data.

Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.

Comparing screening mammography for early breast cancer detection in Vermont and Norway.

Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.

Markov models of breast tumor progression: some age-specific results.

Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.

Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.

Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program--the Oslo II Study.

Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.

Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.

Quantitative target sizes for breast tumor detection prior to metastasis: a prerequisite to rational design of 4D scanners for breast screening.

Breast cancer screening by mammography in women aged under 50 years in Japan.

Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase.

Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts.

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

[Early results of breast cancer screening research]

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

Risk for distant recurrence of breast cancer detected by mammography screening or other methods.

Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.